receives

BIO-key Receives Notice of Non-Compliance from Nasdaq Related to Delay of its Form 10-K Filing

HOLMDEL, N.J., April 22, 2026 (GLOBE NEWSWIRE) -- BIO-key International, Inc. (Nasdaq: BKYI), a global leader in Identity and Access Management…

1 month ago

Brigade Electronics Receives Frost & Sullivan’s 2026 European Market Leadership Recognition in the Commercial Vehicle Safety Systems Industry for Excellence in Fleet-Wide Safety Technology Standardization

Brigade Electronics is a leading hardware-centric supplier for leveraging safety regulations and fleet-wide technology to deliver reliable, user-friendly solutions.SAN ANTONIO,…

1 month ago

Frost & Sullivan: Innovapptive Receives the 2026 Global Augmented Connected Worker, End-to-End Platforms Company of the Year Recognition for Excellence in AI-Powered Connected Worker Execution

Recognized for advancing platform development and enabling unified execution layer capabilities that transform frontline workflows and operational efficiency.SAN ANTONIO, April…

1 month ago

Lumen Receives Frost & Sullivan’s 2026 North American Broadcast Video Managed Services Recognition for Excellence in Purpose-Built Broadcast Reliability and Operational Efficiency

Recognized for delivering purpose-built broadcast services that enhance operational efficiency, reliability, and seamless end-to-end workflow integration.SAN ANTONIO, April 20, 2026…

1 month ago

MISTRAS Group Receives Frost & Sullivan’s 2026 Global NDT Field Inspection Services Company of the Year Recognition for Excellence in Integrated Asset Integrity and Digital Execution

MISTRAS Group delivers customer-centric asset integrity solutions that drive operational efficiency and performance improvement across global industries.SAN ANTONIO, April 14,…

1 month ago

Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia

Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with approximately 4–5 million patients, with launch planned during 2026QUVIVIQ®…

1 month ago

Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil in Duchenne Muscular Dystrophy – CORRECTION

April 10, 2026 16:09 ET  | Source: Mesoblast Limited Working with Parent Project Muscular Dystrophy and the Duchenne Registry on…

1 month ago

Replimune Receives Complete Response Letter from the FDA for RP1 Biologics License Application for the Treatment of Advanced Melanoma

April 10, 2026 17:02 ET  | Source: Replimune, Inc. WOBURN, Mass., April 10, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc.…

1 month ago

Vonage Receives Frost & Sullivan’s 2025 Asia-Pacific Communications Platform-as-a-Service Company of the Year Recognition

Vonage is recognized for its market leadership in omnichannel communications, trusted brand experiences, and deep vertical expertise.SAN ANTONIO, April 7,…

2 months ago

AT&T Receives Frost & Sullivan’s 2026 US Public Safety Solutions Company of the Year Recognition for Excellence in Mission-Critical Connectivity

AT&T is recognized for advancing public safety communications through ubiquitous connectivity, innovation, and a resilient network architecture through FirstNet, Built…

2 months ago